Ingalls’ operating performance was below budget in fiscal year 2018 due to material one-time write-offs and weak volume trends, though Moody’s affirmation of the rating heavily incorporates Ingalls’ close affiliation with University of Chicago Medicine.
The rating outlook has been revised from stable to negative.
More articles on healthcare finance:
Walmart increasingly comparing physicians over cost: 5 things to know
Arkansas hospital operator ousted over ‘real and present danger’ to assets
Dueling healthcare policy proposals spark $40B stock sell-off
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
